|
HS Code |
951102 |
| Product Name | Fmoc-L-3,4-Dichlorophe |
| Chemical Name | Fmoc-L-3,4-dichlorophenylalanine |
| Cas Number | 186551-34-8 |
| Molecular Formula | C24H17Cl2NO4 |
| Molecular Weight | 454.30 |
| Appearance | white to off-white powder |
| Purity | ≥98% |
| Storage Temperature | 2-8°C |
| Solubility | DMSO, DMF, acetonitrile |
| Protecting Group | Fmoc |
| Optical Activity | [α]D20 +9° (c=1, MeOH) |
| Usage | peptide synthesis |
| Synonyms | 9-Fluorenylmethyloxycarbonyl-L-3,4-dichlorophenylalanine |
| Melting Point | N/A |
| Shipment Conditions | ambient temperature |
As an accredited Fmoc-L-3,4-Dichlorophe factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical Fmoc-L-3,4-Dichlorophe is packaged in a 1-gram amber glass vial, sealed for moisture and light protection. |
| Shipping | The chemical Fmoc-L-3,4-Dichlorophe is shipped in secure, tightly-sealed containers to prevent contamination and moisture exposure. Packaging complies with international regulations for hazardous chemicals, including labeling and documentation. Temperature controls and appropriate cushioning are used to ensure safe transport. Shipping is typically via certified chemical carriers with tracking. |
| Storage | Fmoc-L-3,4-Dichlorophenylalanine should be stored in a cool, dry, and well-ventilated area, tightly sealed in its original container. Keep it away from light, heat sources, and incompatible materials such as strong oxidizing agents. Store at 2–8°C (refrigerated) for optimal stability. Ensure proper labeling and avoid moisture exposure to maintain the compound’s integrity. |
Applications of Fmoc-L-3,4-Dichlorophenylalanine in Industrial ManufacturingAs a core manufacturer of Fmoc-L-3,4-Dichlorophenylalanine, we deliver this protected amino acid for diverse downstream integrations in advanced industrial synthesis. Below we detail distinct application sectors, each with unique compliance regimes, formulation ratios, processing entry points, and types of finished goods in routine global manufacturing practice. 1. Peptide Drug Substance SynthesisThis raw material functions as a protected building block in peptide API manufacturing, especially for research and commercial peptides where dichloro-phenylalanine modification enhances target affinity or metabolic stability. It enters the solid-phase peptide synthesis workflow, often prepared via Fmoc/tBu protocols. It supports custom and GMP-driven processes for anti-cancer, metabolic, and neuropeptide pharmaceuticals, with precise quality tracking from incoming QC to validated final API batch release. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Pharmaceutical Reference Material ProductionThis compound is essential in the synthesis of highly pure peptide fragments used as analytical reference standards. Laboratories and QC providers use it to introduce stable isotopic or halogen modifications into calibration materials. Controlled handling and traceability underpin its application, requiring strict conformity to analytical reference specifications and minimization of contaminant carryover, enabling precise calibration of pharmaceutical assays and regulatory batch release protocols worldwide. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Bioconjugation and Targeted Drug Delivery ResearchFmoc-protected dichlorophenylalanine acts as a specialized linker or reactive handle incorporated into carrier peptides or antibody–drug conjugates (ADCs). It creates hydrophobic and sterically demanding interaction points, improving stability or biological targeting in preclinical studies. The material is integrated at the peptide-resin assembly stage and undergoes site-specific deprotection and conjugation, all while maintaining rigorous control over purity and batch records to support regulatory submissions and downstream toxicological evaluation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Custom Peptide Library Synthesis for High-Throughput ScreeningFmoc-L-3,4-Dichlorophenylalanine is a core input in combinatorial peptide library production for drug discovery and functional screening platforms. It introduces defined structural motifs, supporting structure–activity relationship (SAR) studies and hit-to-lead optimization. The raw material is fully traceable through library pool tracking and QC, and its controlled purity aids in reducing background noise for high-throughput binding or inhibition screens in both automated and manual peptide synthesis platforms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Fmoc-L-3,4-Dichlorophe prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing Fmoc-L-3,4-Dichlorophe as a manufacturer demands constant attention to both raw material quality and the intricacies of synthetic chemistry. In our work, the choice of every reagent and each process step leaves a mark on reliability and consistency. Fmoc-L-3,4-Dichlorophe, known among synthesis experts for its precise protection and functional application, stands out among protected amino acid derivatives. Chemists rely on its dependable Fmoc-protected group for assembling custom peptides, particularly when seeking to modify biological functionality or explore protein structure relationships.
Our product’s systematic identity arises from a logical process: starting with L-3,4-dichlorophenylalanine, we introduce the 9-fluorenylmethoxycarbonyl group. Through this method, we protect the amine while maintaining chiral integrity and steric characteristics similar to native amino acids, only modified with a dichlorinated aromatic ring. The lot consistency we maintain—batch after batch—reflects years of improving methods and instrument calibration, eliminating the guesswork that plagues less controlled sources. Purity levels, verified through NMR, HPLC, and elemental analysis, consistently reach 98% or higher, matching or surpassing research-grade standards expected in both academic and pharmaceutical labs.
Peptide chemists search for more than just Fmoc-protected amino acids; they need molecules they can trust in the lab. This is never truer than with analogues like Fmoc-L-3,4-Dichlorophe. Any inconsistencies in substitution patterns, racemization, or contamination lead to frustrated hours, failed syntheses, and wasted funding. Commercial traders and resellers may repackage or relabel without adequate oversight, so those in the know look to manufacturers for true sourcing. Our process begins with traceable procurement of raw L-3,4-dichlorophenylalanine, followed by validated functionalization steps and analytical confirmation. What arrives in the user’s hands reflects a tight circle: only batches that pass rigorous internal checkpoints join our offering.
Our experience in manufacturing is rooted in listening and learning from our customer base. As pharmaceutical firms and university labs reported issues with competitors—unexpected mass peaks, shifts in optical rotation, impurities above the 2% level—we refined both our reaction quenching protocols and solid-phase column washing techniques. By carefully washing and vacuum-drying final product, and by using narrowly defined storage parameters, we avoid breakdown of the Fmoc group and oxidative changes to the aromatic system. The consistency users find in our Fmoc-L-3,4-Dichlorophe lets them spend time optimizing sequences and yields, instead of isolating or troubleshooting contaminants.
Researchers reach for Fmoc-L-3,4-Dichlorophe in many scenarios. This derivative fits easily into standard Fmoc solid-phase peptide synthesis protocols, becoming part of growing peptide chains on resin supports. Its ortho- and para-chlorinated phenyl ring attracts interest in medicinal chemistry for mimicking halogenated residues common to biologically active peptides. Medicinal chemists use such modifications to probe receptor interactions, resist enzymatic degradation, or adjust hydrophobicity and steric effects. Those working in biosensors, custom catalysts, and enzyme-mimetic systems find similar value in introducing dichlorinated aromatics. In each setting, product reliability and consistent protecting group stability matter more than buzzword claims or exotic marketing. Time saved recovering from a failed synthesis often outpaces savings from lower-cost, lower-purity alternatives.
Fmoc-L-3,4-Dichlorophe offers advantages over similar protected amino acids, especially in tuning peptide and small protein behavior. Unmodified phenylalanine imparts bulk and nonpolarity, but the introduction of two chlorine atoms changes both electronic and spatial properties. This alteration changes binding interactions in biologically relevant peptides, a phenomenon explored in recent literature. The demand for such building blocks grows as peptide-based drugs evolve. Where Fmoc-protected L-phenylalanine works for standard library synthesis, dichloro substitution supports research into protease-resistant sequences or enhances activity in peptide antibiotics and hormone mimetics. We also see synthetic progress in peptidomimetics seeking to combine natural and non-natural amino acid features. Fmoc-L-3,4-Dichlorophe is uniquely suited for these projects, enduring the full range of standard deprotection, activation, and coupling protocols without losing its integrity.
Our team spends years studying reagent handling and process improvement, and those lessons manifest in each vial of Fmoc-L-3,4-Dichlorophe. Many amino acid analogues compare on paper, but the analogy breaks down during actual peptide assembly. For example, unchlorinated Fmoc-phenylalanine or even simple mono-chlorinated derivatives often fall short in projects that require maximal hydrophobic tuning or precise disruption of aromatic stacking. The increased chlorination changes electron density and improves the residue’s ability to stand in for non-standard aromatic signals in peptide NMR investigations. Researchers who rely on crystallography or detailed NMR benefit from a well-characterized, traceable product; unknown or mixed isomer content in poorly sourced batches can confuse or invalidate results.
Handling and solubility properties set our material apart from stickier or unevenly crystallized analogues. Each lot passes through several crystallization and drying steps to assure ease of transfer, minimal clumping, and reproducible weighing—a minor outcome until a high-throughput synthesis fails due to poor mixing or dosing. For those scaling syntheses from milligrams to grams, having a non-hygroscopic and free-flowing solid can prevent unwanted side reactions or physical loss. Such practical considerations get overlooked in superficial spec sheets, but we believe these details matter most. We often field feedback on shipment durability, and direct experience shapes both our bulk and small-quantity packaging techniques.
Any time chlorinated aromatics become part of the workflow, our manufacturing protocols place special emphasis on containment and worker safety. Our adherence to modern air handling, solvent recovery, and protective equipment guidelines ensures a safe workplace and minimizes both environmental impact and regulatory risk. Fmoc-L-3,4-Dichlorophe does not belong on the list of especially hazardous compounds, but conscientious operations avoid fugitive dust, unnecessary solvent exposure, and improper waste. With every kilogram packaged, staff verify compliance not just with internal standards, but with updated national and international shipping and disposal guidelines. Careful planning on our part removes that burden from our customers. Many of our long-term partners told us their move toward greener, safer laboratories began with reliable, well-documented chemical sourcing, and we believe this raises everyone’s standards over time.
Sustainability efforts also show up in our procurement strategy. We prioritize raw materials from transparent suppliers with secure, stable supply chains. Our solvent and wash liquid recycling programs, and proper neutralization of acidic and basic byproducts, keep our waste generation in check. Past years saw us develop new methods that lowered energy use per batch; these changes help control manufacturing costs and shrink our footprint, benefits which we try to share in both our pricing and our industry influence. Reliable chemical manufacturing now depends on a willingness to revisit each process, not just in response to external standards, but to continuously improve the working environment for chemists at every stage—from our facility to the end user’s lab.
Chemists working at the frontier of peptide research often lament inconsistent yields, trace contamination, and the unpredictable solubility of building blocks. These issues seldom trace to user error or flaws in solid-phase hardware. Rather, they stem from under-characterized reagents, poorly controlled intermediates, or slow response to emerging synthetic demands. From the outset, our manufacturing team gathered feedback from diverse customers: professors developing new labeling reagents, biotech firms optimizing protease inhibitors, and startups designing next-generation peptide drugs. Calls and emails often point to troubling results with unrelated products—crystalline residues that absorb water unpredictably, unreliable molar equivalence readings, and impurity peaks in HPLC traces. We take each complaint as a learning opportunity and initiate internal reviews or process redesign as needed.
By building feedback loops and continuous quality monitoring into our manufacturing culture, we have observed a long-term decrease in customer complaints and product returns. This relationship goes well beyond batch control—chemists who trust their reagents tend to innovate more confidently. They invest less time troubleshooting the basics and more on complex assemblies or exploratory structure-activity relationships. In the field of peptide chemistry, marginal gains in reliability amplify final research rewards. Our track record of successful partnerships with both leading universities and pharmaceutical development teams reflects the trust placed in our Fmoc-L-3,4-Dichlorophe and the philosophy behind its production.
The field of peptide research continues moving forward; new chemical tools emerge as each class of peptides and proteins creates fresh research questions. We face growing requests from the biotechnology sector, which increasingly depends on non-standard building blocks for peptidomimetic drugs, diagnostic probes, and complex assembly strategies. Even niche segments—such as modified peptide libraries for high-throughput screening or hydrogel-forming peptides—require amino acids that deliver both reliability and functional uniqueness. The dichloro substitution pattern in Fmoc-L-3,4-Dichlorophe enables this progress, serving roles far beyond those of standard Fmoc-phenylalanine or mono-chlorinated analogues. In our own product improvement meetings, we discuss patterns in customer requests, application notes, and synthesis failures, letting these conversations guide our future investment in manufacturing scalability and process safety.
Our technical support staff work directly with researchers scaling gram- to kilogram-level syntheses. Common hurdles include inconsistent coupling reactions, incomplete deprotection, or chain truncation. Whereas many issues disappear with improvements in resin and coupling agent quality, the starting amino acid derivatives still define the upper limit of attainable purity and yield. We field questions from chemists designing isotopically labeled or difficult-to-sequence peptides—scenarios where only the purest, most consistent building blocks suffice. Investment in better purification, more selective chromatography, and enhanced analytical control continues in tandem with customer needs. Our product development pipeline adapts as the horizon of peptide research stretches, rather than resting on the status quo.
Fmoc-L-3,4-Dichlorophe enters the market alongside a host of protected amino acid derivatives, but use cases often highlight fundamental differences. Practicing chemists know that mono-chlorinated or unchlorinated analogues often fall short in certain biological or conformational studies. The di-chloro substitution opens unique doors for mimicking non-natural peptide motifs, increasing resistance to enzymatic cleavage, and enabling the study of halogen effects in peptide backbone engineering. Many of our customers cite the precise melting point, good solubility in DMF and DCM, and high batch-to-batch consistency that we deliver. Analytical HPLC traces for our Fmoc-L-3,4-Dichlorophe display clean, narrow peaks: evidence that contaminant levels remain below pharmacologically relevant thresholds. These practical details count in research settings where both efficiency and interpretive power matter.
Other protected phenylalanine analogues may suffice for high-throughput, routine synthesis, but Fmoc-L-3,4-Dichlorophe’s added functionality becomes crucial in targeted applications such as peptide drug scaffolds, receptor mapping, and structure-activity relationship exploration. The product’s compatibility with all major coupling protocols—DIC/HOBt, HATU, and other carbodiimide methods—comes from years of incremental improvement, not from simple emulation of competitor formulas. Chemists with specialized purity or stability needs see the outcome in consistent mass spectrometry profiles and high yields in challenging sequences.
The challenge of making Fmoc-L-3,4-Dichlorophe available at the level serious researchers expect rests on more than a clean synthetic procedure. No synthetic method alone produces world-class results unless combined with careful quality control, deep process knowledge, and open lines of communication with end users. Our years spent refining crystallization, storage, handling, and transportation translate into reliable results on the bench. The expectations for modern peptide chemists are high: rapid prototyping, robust reproducibility, and ever-shrinking error bars. These outcomes depend on a cycle of trust, where manufacturers remain responsive to feedback and committed to improvement at every level.
As the capabilities of peptide-based research advance—into new therapeutics, diagnostics, and materials—the role of specialized building blocks like Fmoc-L-3,4-Dichlorophe grows in importance. Our hands-on experience as a manufacturer—years spent optimizing yields, purifying critical intermediates, troubleshooting unexpected results—defines our ability to support the next generation of researchers. Each refinement in production, every dialogue with the bench chemists using our products, and each lot released with pride underpins the continuing evolution of peptide science.